These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38282640)

  • 1. Elucidation of Molecular Interactions Between Drug-Polymer in Amorphous Solid Dispersion by a Computational Approach Using Molecular Dynamics Simulations.
    Aulifa DL; Al Shofwan AA; Megantara S; Fakih TM; Budiman A
    Adv Appl Bioinform Chem; 2024; 17():1-19. PubMed ID: 38282640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Study of the Pharmaceutical Properties between Amorphous Drugs Loaded-Mesoporous Silica and Pure Amorphous Drugs Prepared by Solvent Evaporation.
    Budiman A; Aulifa DL
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS; Taylor LS
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
    Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
    AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers.
    Homayouni A; Sadeghi F; Nokhodchi A; Varshosaz J; Garekani HA
    Iran J Basic Med Sci; 2014 May; 17(5):322-31. PubMed ID: 24967060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly Water-Soluble Solid Dispersions of Honokiol: Preparation, Solubility, and Bioavailability Studies and Anti-Tumor Activity Evaluation.
    Wang L; Wu W; Wang L; Wang L; Zhao X
    Pharmaceutics; 2019 Nov; 11(11):. PubMed ID: 31683964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of plasticizers on manufacturing ritonavir/copovidone solid dispersions via hot-melt extrusion: Preformulation, physicochemical characterization, and pharmacokinetics in rats.
    Zhao Y; Xie X; Zhao Y; Gao Y; Cai C; Zhang Q; Ding Z; Fan Z; Zhang H; Liu M; Han J
    Eur J Pharm Sci; 2019 Jan; 127():60-70. PubMed ID: 30343153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin.
    Dengale SJ; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Biopharm; 2015 Jan; 89():329-38. PubMed ID: 25542681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational approach to elucidate the formation and stabilization mechanism of amorphous formulation using molecular dynamics simulation and fragment molecular orbital calculation.
    Ma X; Higashi K; Fukuzawa K; Ueda K; Kadota K; Tozuka Y; Yonemochi E; Moribe K
    Int J Pharm; 2022 Mar; 615():121477. PubMed ID: 35051536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
    Ramadhani N; Shabir M; McConville C
    Int J Pharm; 2014 Nov; 475(1-2):514-22. PubMed ID: 25218186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of a ternary amorphous solid dispersion using hot-melt extrusion for obtaining a stable colloidal dispersion of amorphous probucol nanoparticles.
    Hanada N; Higashi K; Zhao Z; Ueda K; Moribe K
    Int J Pharm; 2023 Jun; 640():122959. PubMed ID: 37086931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.
    Faiz Afzal MA; Lehmkemper K; Sobich E; Hughes TF; Giesen DJ; Zhang T; Krauter CM; Winget P; Degenhardt M; Kyeremateng SO; Browning AR; Shelley JC
    Mol Pharm; 2021 Nov; 18(11):3999-4014. PubMed ID: 34570503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB; Lodagekar A; Yadav B; Shastri NR
    Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Cooling on the Degree of Crystallinity, Solid-State Properties, and Dissolution Rate of Multi-Component Hot-Melt Extruded Solid Dispersions.
    Hurley D; Davis M; Walker GM; Lyons JG; Higginbotham CL
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32121578
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioavailability enhancement of a BCS IV compound via an amorphous combination product containing ritonavir.
    Miller DA; Keen JM; Brough C; Ellenberger DJ; Cisneros M; Williams RO; McGinity JW
    J Pharm Pharmacol; 2016 May; 68(5):678-91. PubMed ID: 26454138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.
    Yang R; Zhang GGZ; Zemlyanov DY; Purohit HS; Taylor LS
    Pharm Res; 2023 Dec; 40(12):2817-2845. PubMed ID: 37052841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.